Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Somatic Mutations of the Breast Cancer Amplified Sequence-1 (BCAS1 ), a Novel Leukemogenic Driver in Myelodysplastic Syndromes with Del(20q)

Valeria Visconte, PhD, Ali Tabarroki, MD, John Barnard, Li Zhang, Juraj Bodo, PhD, Reda Mahfouz, MD, Betty K. Hamilton, MD, Mikkael Sekeres, Anjali S. Advani, MD, Matt E. Kalaycio, MD, Yogen Saunthararajah, MD, Velizar Shivarov, MD, PhD, Shashirekha Shetty, PhD, Heesun J. Rogers, MD PhD, Ramon V. Tiu, MD

Blood (2014) 124 (21): 3250.

https://doi.org/10.1182/blood.V124.21.3250.3250

Published: 2014

Journal Articles

Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine

Donald Lavelle, Kestis Vaitkus, Yonghua Ling, Maria A. Ruiz, Reda Mahfouz, Kwok Peng Ng, Soledad Negrotto, Nicola Smith, Pramod Terse, Kory J. Engelke, Joseph Covey, Kenneth K. Chan, Joseph DeSimone, Yogen Saunthararajah

Blood (2012) 119 (5): 1240–1247.

https://doi.org/10.1182/blood-2011-08-371690

Published: 2012

Includes: Supplemental data

Journal Articles

EZH2 Is Either Mutated or Downregulated in Patients with Loss of Heterozygosity of Chromosome 7/7q and Leads to Epigenetic Dysregulation Via Histone H3K27.

Hideki Makishima, MD, PhD, Shahper N Khan, PhD, Anna M Jankowska, PhD, Yuka Sugimoto, MD, Zhenbo Hu, MD, Venugopalan Cheriyath, PhD, Reda Mahfouz, MD, Quteba Ebrahem, MD, Sergei Vatolin, PhD, Yogen Saunthararajah, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P Maciejewski, MD, PhD, FACP

Blood (2011) 118 (21): 228.

https://doi.org/10.1182/blood.V118.21.228.228

Published: 2011

Journal Articles

Effective and Non-Cytotoxic p53 Independent Epigenetic-Differentiation Therapy In Xeno-Transplant Models of Human Acute Myeloid Leukemia

Kwok Peng Ng, PhD, Quteba Ebrahem, MD, Soledad Negrotto, PhD, Reda Mahfouz, MD, Kevin Link, PhD, Zhenbo Hu, MD, Xiaorong Gu, PhD, Anjali Advani, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, Edward A. Copelan, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, James C. Mulloy, PhD, Yogenthiran Saunthararajah, MD

Blood (2010) 116 (21): 3309.

https://doi.org/10.1182/blood.V116.21.3309.3309

Published: 2010

Journal Articles

Identification of Oncogenic EZH2 Mutations In Myelodysplastic Syndromes and Related Myeloid Malignancies

Hideki Makishima, MD, PhD, Ania Jankowska, MSC, Ramon V. Tiu, MD, Hadrian Szpurka, PhD, MSC, Yuka Sugimoto, MD, PhD, Quteba Ebrahem, MD, Zhenbo Hu, MD, Reda Mahfouz, MD, Yogen Saunthararajah, MD, Kathryn Guinta, Mehdi Keddache, MSC, Christine L. O'Keefe, PhD, Mikkael A. Sekeres, MD, MS, Alan F. List, Michael A McDevitt, MD, PhD, Jaroslaw P Maciejewski, MD, PhD, FACP

Blood (2010) 116 (21): 607.

https://doi.org/10.1182/blood.V116.21.607.607

Published: 2010

NARROW

Somatic Mutations of the Breast Cancer Amplified Sequence-1 (BCAS1 ), a Novel Leukemogenic Driver in Myelodysplastic Syndromes with Del(20q)

Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine

EZH2 Is Either Mutated or Downregulated in Patients with Loss of Heterozygosity of Chromosome 7/7q and Leads to Epigenetic Dysregulation Via Histone H3K27.

Effective and Non-Cytotoxic p53 Independent Epigenetic-Differentiation Therapy In Xeno-Transplant Models of Human Acute Myeloid Leukemia

Identification of Oncogenic EZH2 Mutations In Myelodysplastic Syndromes and Related Myeloid Malignancies

Email alerts

ASH Publications

American Society of Hematology

Somatic Mutations of the Breast Cancer Amplified Sequence-1 (BCAS1 ), a Novel Leukemogenic Driver in Myelodysplastic Syndromes with Del(20q)

Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine

EZH2 Is Either Mutated or Downregulated in Patients with Loss of Heterozygosity of Chromosome 7/7q and Leads to Epigenetic Dysregulation Via Histone H3K27.

Effective and Non-Cytotoxic p53 Independent Epigenetic-Differentiation Therapy In Xeno-Transplant Models of Human Acute Myeloid Leukemia

Identification of Oncogenic EZH2 Mutations In Myelodysplastic Syndromes and Related Myeloid Malignancies

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only